Editorial
World J Virol
10(2):30-33.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.30
Abstract (752)
|
Core Tip (730)
|
Full Article (HTML) (1871)
|
Figures (1-4) (631)
|
Full Article (PDF)-1129K (294)
|
Audio-540K (10)
|
Peer-Review Report-149K (136)
|
Answering Reviewers-64K (119)
|
Received: 01/14/2021
|
Revised: 01/30/2021
|
Accepted: 02/05/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (8062)
|
Similar Articles (1)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
World J Virol
10(2):34-52.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.34
Abstract (1371)
|
Core Tip (884)
|
Full Article (HTML) (10570)
|
Tables (1-3) (354)
|
Full Article (PDF)-950K (966)
|
Audio-1256K (29)
|
Peer-Review Report-242K (264)
|
Answering Reviewers-119K (281)
|
Received: 12/29/2020
|
Revised: 01/23/2021
|
Accepted: 03/12/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (14)
|
Total Visits (19707)
|
Similar Articles (702)
|
Timeline of Article Publication (1)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review
World J Virol
10(2):53-61.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.53
Abstract (754)
|
Core Tip (766)
|
Full Article (HTML) (2574)
|
Tables (1-3) (369)
|
Full Article (PDF)-837K (248)
|
Audio-1070K (28)
|
Peer-Review Report-217K (142)
|
Answering Reviewers-69K (147)
|
Received: 12/12/2020
|
Revised: 01/28/2021
|
Accepted: 03/08/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8282)
|
Similar Articles (690)
|
Timeline of Article Publication (9)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza
World J Virol
10(2):62-68.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.62
Abstract (748)
|
Core Tip (733)
|
Full Article (HTML) (2731)
|
Figures (1-2) (376)
|
Tables (1-3) (307)
|
Full Article (PDF)-4630K (329)
|
Audio-444K (3)
|
Peer-Review Report-202K (154)
|
Answering Reviewers-117K (179)
|
Received: 12/18/2020
|
Revised: 01/16/2021
|
Accepted: 02/20/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (9436)
|
Similar Articles (792)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Epidemiological characterization and geographic distribution of human immunodeficiency virus/acquired immunodeficiency syndrome infection in North African countries
World J Virol
10(2):69-85.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.69
Abstract (822)
|
Core Tip (764)
|
Article Highlights (829)
|
Full Article (HTML) (3287)
|
Figures (1-8) (393)
|
Tables (1-1) (378)
|
Full Article (PDF)-10779K (282)
|
Audio-581K (24)
|
Peer-Review Report-162K (181)
|
Answering Reviewers-206K (182)
|
Received: 11/04/2020
|
Revised: 12/22/2020
|
Accepted: 01/08/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (11233)
|
Similar Articles (1)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open